Author:
Inokoshi Junji,Shigeta Naoki,Fukuda Takashi,Uchida Ryuji,Nonaka Kenichi,Masuma Rokurou,Tomoda Hiroshi
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference24 articles.
1. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus with reduced susceptibility to vancomycin-United States. Morb. Mortal. Wkly. Rep 46, 765–766 (1997).
2. Hiramatsu, K. et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135–136 (1997).
3. Fowler, V. G. Jr et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355, 653–665 (2006).
4. Irinoda, K., Nomura, S. & Hashimoto, M. Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug. Nihon. Yakurigaku. zasshi. 120, 245–252 (2002) in Japanese.
5. Walsh, C. T. Antibiotics: Actions, Origins, Resistance, ASM Press: Washington, DC, (2003).
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献